Gipson Lawrence L MD is categorized under Family Practice Doctors in Charleroi, PA and active since 1998.
Gipson Lawrence L MD was established in 1998, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lawrence Gipson at the company’s single location by writing to 305 Mckean Avenue, Charleroi, Pennsylvania PA 15022 or by phoning (724) 483-8065. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gipson Lawrence L MD |
| Contact Person: | Lawrence Gipson |
| Address: | 305 Mckean Avenue, Charleroi, Pennsylvania 15022 |
| Phone Number: | (724) 483-8065 |
| Website Address: | neovisioneyes.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gipson Lawrence L MD was started in 1998 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Lawrence Gipson for inquiries that concern Gipson Lawrence L MD by calling the company number (724) 483-8065, as your correspondence is most welcome. Additionally, the physical location of the single location of Gipson Lawrence L MD can be found at the coordinates 40.13675,-79.89559 as well as the street address 305 Mckean Avenue in Charleroi, Pennsylvania 15022.
For its online presence, you may visit Gipson Lawrence L MD’s website at neovisioneyes.com and engage with its social media outlets through on Twitter and on Facebook.